These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35335674)

  • 1. Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination.
    Arnason NA; Johannsson F; Landrö R; Hardarsson B; Gudmundsson S; Lian AM; Reseland J; Rolfsson O; Sigurjonsson OE
    Pathogens; 2022 Mar; 11(3):. PubMed ID: 35335674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions.
    Arnason NA; Johannson F; Landrö R; Hardarsson B; Irsch J; Gudmundsson S; Rolfsson O; Sigurjonsson OE
    Transfusion; 2019 Dec; 59(12):3727-3735. PubMed ID: 31674051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminator.
    Brouard N; Pissenem-Rudwill F; Mouriaux C; Haas D; Galvanin A; Kientz D; Mangin PH; Isola H; Hechler B
    Transfusion; 2023 Oct; 63(10):1937-1950. PubMed ID: 37615493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.
    Thiele T; Sablewski A; Iuga C; Bakchoul T; Bente A; Görg S; Völker U; Greinacher A; Steil L
    Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s63-70. PubMed ID: 22890270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of pathogen inactivated platelet quality: An 8 year experience of routine use in Galicia, Spain.
    Castrillo Fernández A; Lanteri MC; Arcas Otero C; Díaz Pereira A; Adelantado Pérez M
    Transfus Apher Sci; 2019 Feb; 58(1):87-93. PubMed ID: 30579750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.
    Knutson F; Alfonso R; Dupuis K; Mayaudon V; Lin L; Corash L; Högman CF
    Vox Sang; 2000; 78(4):209-16. PubMed ID: 10895093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
    Bertaggia Calderara D; Crettaz D; Aliotta A; Barelli S; Tissot JD; Prudent M; Alberio L
    Transfusion; 2018 Oct; 58(10):2395-2406. PubMed ID: 30229925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction.
    Isola H; Ravanat C; Rudwill F; Pongerard A; Haas D; Eckly A; Gachet C; Hechler B
    Transfusion; 2021 Mar; 61(3):919-930. PubMed ID: 33527430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.
    Infanti L; Holbro A; Passweg J; Bolliger D; Tsakiris DA; Merki R; Plattner A; Tappe D; Irsch J; Lin JS; Corash L; Benjamin RJ; Buser A
    Transfusion; 2019 Nov; 59(11):3350-3361. PubMed ID: 31574181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in stored platelet concentrates.
    Bubel S; Wilhelm D; Entelmann M; Kirchner H; Klüter H
    Transfusion; 1996 May; 36(5):445-9. PubMed ID: 8693510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.
    Hechler B; Ohlmann P; Chafey P; Ravanat C; Eckly A; Maurer E; Mangin P; Isola H; Cazenave JP; Gachet C
    Transfusion; 2013 Jun; 53(6):1187-200. PubMed ID: 23067365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen inactivation treatment of triple-dose apheresis platelets with amotosalen and ultraviolet a light.
    Infanti L; Pehlic V; Mitrovic S; Holbro A; Andresen S; Payrat JM; Lin JS; Buser A
    Transfus Med; 2022 Dec; 32(6):505-511. PubMed ID: 36124649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C.
    Lozano M; Escolar G; Mazzara R; Connor J; White JG; DeLecea C; Ordinas A
    Transfusion; 2000 May; 40(5):527-34. PubMed ID: 10827254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.
    Ohlsson S; Diedrich B; Uhlin M; Sandgren P
    Vox Sang; 2018 Oct; 113(7):611-621. PubMed ID: 30156292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination.
    Kumar A; Tiwari AK; Kumar S; Biswas A; Singh G; Chatterjee K; Chakroborty S; Sunil S
    Asian J Transfus Sci; 2022; 16(1):67-72. PubMed ID: 36199414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage.
    Glenister KM; Payne KA; Sparrow RL
    Transfusion; 2008 Jan; 48(1):99-107. PubMed ID: 17894789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
    Lozano M; Galan A; Mazzara R; Corash L; Escolar G
    Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.
    Abonnenc M; Sonego G; Crettaz D; Aliotta A; Prudent M; Tissot JD; Lion N
    Transfusion; 2015 Sep; 55(9):2219-30. PubMed ID: 25873361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.
    Tynngård N; Wikman A; Uhlin M; Sandgren P
    Blood Transfus; 2020 May; 18(3):191-199. PubMed ID: 31403931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.
    Sandgren P; Diedrich B
    Vox Sang; 2015 May; 108(4):340-9. PubMed ID: 25557354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.